HLB Co., Ltd.
028300
Clasificación en acciones
#4140
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Precio por acción
$29.28
Capitalización bursátil
$3.89B
Cambio (1 día)
-1.40%
Cambio (1 año)
-8.45%
País
KR
Comercio HLB Co., Ltd. (028300)
Categoría
Healthcare
Número de acciones en circulación de HLB Co., Ltd. (028300)
Número de acciones en circulación al June 2026: 132.90M
Según los últimos informes financieros y el precio de las acciones de HLB Co., Ltd., el número actual de acciones en circulación es 132.90M. Al final de December 2023, la empresa tenía 121.24M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de HLB Co., Ltd. (028300) desde 2012 hasta 2026
Acciones en circulación al final de cada año
| Año | Acciones en circulación | Cambiar |
|---|---|---|
| 2026 (TTM) | 132.90M | 1.68% |
| 2024 | 130.70M | 7.81% |
| 2023 | 121.24M | 7.68% |
| 2022 | 112.59M | -6.32% |
| 2021 | 120.18M | -2.83% |
| 2020 | 123.68M | 22.11% |
| 2019 | 101.28M | 6.04% |
| 2018 | 95.51M | 4.49% |
| 2017 | 91.40M | 0.94% |
| 2016 | 90.55M | 7.76% |
| 2015 | 84.04M | 34.50% |
| 2014 | 62.48M | 7.44% |
| 2013 | 58.16M | 20.89% |
| 2012 | 48.11M | 0.00% |
Acciones en circulación de empresas similares o competidores
| Empresa | Acciones en circulación | Diferencia | País |
|---|---|---|---|
| 253.90M | 91.04% |
US
|
|
| 396.00M | 197.96% |
US
|
|
| 478.91M | 260.35% |
AU
|
|
| 62.19M | -53.21% |
NL
|
|
| - | - |
CH
|
